Eintrag weiter verarbeiten
3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC)
Gespeichert in:
| Zeitschriftentitel: | European Journal of Cancer Supplements |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , |
| In: | European Journal of Cancer Supplements, 5, 2007, 4, S. 235 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Elsevier BV
|
| Schlagwörter: |
| author_facet |
van Cutsem, E. Bodoky, G. Kyung Roh, J. Folprecht, G. Park, Y.S. van Laethem, J.L. Raoul, J.L. Ciardiello, F. Lebrun, P. Rougier, P. van Cutsem, E. Bodoky, G. Kyung Roh, J. Folprecht, G. Park, Y.S. van Laethem, J.L. Raoul, J.L. Ciardiello, F. Lebrun, P. Rougier, P. |
|---|---|
| author |
van Cutsem, E. Bodoky, G. Kyung Roh, J. Folprecht, G. Park, Y.S. van Laethem, J.L. Raoul, J.L. Ciardiello, F. Lebrun, P. Rougier, P. |
| spellingShingle |
van Cutsem, E. Bodoky, G. Kyung Roh, J. Folprecht, G. Park, Y.S. van Laethem, J.L. Raoul, J.L. Ciardiello, F. Lebrun, P. Rougier, P. European Journal of Cancer Supplements 3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC) Cancer Research Oncology |
| author_sort |
van cutsem, e. |
| spelling |
van Cutsem, E. Bodoky, G. Kyung Roh, J. Folprecht, G. Park, Y.S. van Laethem, J.L. Raoul, J.L. Ciardiello, F. Lebrun, P. Rougier, P. 1359-6349 Elsevier BV Cancer Research Oncology http://dx.doi.org/10.1016/s1359-6349(07)70929-1 3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC) European Journal of Cancer Supplements |
| doi_str_mv |
10.1016/s1359-6349(07)70929-1 |
| facet_avail |
Online |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMTM1OS02MzQ5KDA3KTcwOTI5LTE |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMTM1OS02MzQ5KDA3KTcwOTI5LTE |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 DE-Zwi2 |
| imprint |
Elsevier BV, 2007 |
| imprint_str_mv |
Elsevier BV, 2007 |
| issn |
1359-6349 |
| issn_str_mv |
1359-6349 |
| language |
English |
| mega_collection |
Elsevier BV (CrossRef) |
| match_str |
vancutsem20073001oralcrystalarandomizedphaseiiitrialofcetuximabplusfolfirivsfolfiriinfirstlinemetastaticcolorectalcancermcrc |
| publishDateSort |
2007 |
| publisher |
Elsevier BV |
| recordtype |
ai |
| record_format |
ai |
| series |
European Journal of Cancer Supplements |
| source_id |
49 |
| title |
3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC) |
| title_unstemmed |
3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC) |
| title_full |
3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC) |
| title_fullStr |
3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC) |
| title_full_unstemmed |
3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC) |
| title_short |
3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC) |
| title_sort |
3001 oral crystal, a randomized phase iii trial of cetuximab plus folfiri vs. folfiri in first-line metastatic colorectal cancer (mcrc) |
| topic |
Cancer Research Oncology |
| url |
http://dx.doi.org/10.1016/s1359-6349(07)70929-1 |
| publishDate |
2007 |
| physical |
235 |
| description |
|
| container_issue |
4 |
| container_start_page |
0 |
| container_title |
European Journal of Cancer Supplements |
| container_volume |
5 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792335454642634757 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T14:44:49.181Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=3001+ORAL+CRYSTAL%2C+a+randomized+phase+III+trial+of+cetuximab+plus+FOLFIRI+vs.+FOLFIRI+in+first-line+metastatic+colorectal+cancer+%28mCRC%29&rft.date=2007-09-01&genre=article&issn=1359-6349&volume=5&issue=4&pages=235&jtitle=European+Journal+of+Cancer+Supplements&atitle=3001+ORAL+CRYSTAL%2C+a+randomized+phase+III+trial+of+cetuximab+plus+FOLFIRI+vs.+FOLFIRI+in+first-line+metastatic+colorectal+cancer+%28mCRC%29&aulast=Rougier&aufirst=P.&rft_id=info%3Adoi%2F10.1016%2Fs1359-6349%2807%2970929-1&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792335454642634757 |
| author | van Cutsem, E., Bodoky, G., Kyung Roh, J., Folprecht, G., Park, Y.S., van Laethem, J.L., Raoul, J.L., Ciardiello, F., Lebrun, P., Rougier, P. |
| author_facet | van Cutsem, E., Bodoky, G., Kyung Roh, J., Folprecht, G., Park, Y.S., van Laethem, J.L., Raoul, J.L., Ciardiello, F., Lebrun, P., Rougier, P., van Cutsem, E., Bodoky, G., Kyung Roh, J., Folprecht, G., Park, Y.S., van Laethem, J.L., Raoul, J.L., Ciardiello, F., Lebrun, P., Rougier, P. |
| author_sort | van cutsem, e. |
| container_issue | 4 |
| container_start_page | 0 |
| container_title | European Journal of Cancer Supplements |
| container_volume | 5 |
| description | |
| doi_str_mv | 10.1016/s1359-6349(07)70929-1 |
| facet_avail | Online |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMTM1OS02MzQ5KDA3KTcwOTI5LTE |
| imprint | Elsevier BV, 2007 |
| imprint_str_mv | Elsevier BV, 2007 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2 |
| issn | 1359-6349 |
| issn_str_mv | 1359-6349 |
| language | English |
| last_indexed | 2024-03-01T14:44:49.181Z |
| match_str | vancutsem20073001oralcrystalarandomizedphaseiiitrialofcetuximabplusfolfirivsfolfiriinfirstlinemetastaticcolorectalcancermcrc |
| mega_collection | Elsevier BV (CrossRef) |
| physical | 235 |
| publishDate | 2007 |
| publishDateSort | 2007 |
| publisher | Elsevier BV |
| record_format | ai |
| recordtype | ai |
| series | European Journal of Cancer Supplements |
| source_id | 49 |
| spelling | van Cutsem, E. Bodoky, G. Kyung Roh, J. Folprecht, G. Park, Y.S. van Laethem, J.L. Raoul, J.L. Ciardiello, F. Lebrun, P. Rougier, P. 1359-6349 Elsevier BV Cancer Research Oncology http://dx.doi.org/10.1016/s1359-6349(07)70929-1 3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC) European Journal of Cancer Supplements |
| spellingShingle | van Cutsem, E., Bodoky, G., Kyung Roh, J., Folprecht, G., Park, Y.S., van Laethem, J.L., Raoul, J.L., Ciardiello, F., Lebrun, P., Rougier, P., European Journal of Cancer Supplements, 3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC), Cancer Research, Oncology |
| title | 3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC) |
| title_full | 3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC) |
| title_fullStr | 3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC) |
| title_full_unstemmed | 3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC) |
| title_short | 3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC) |
| title_sort | 3001 oral crystal, a randomized phase iii trial of cetuximab plus folfiri vs. folfiri in first-line metastatic colorectal cancer (mcrc) |
| title_unstemmed | 3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC) |
| topic | Cancer Research, Oncology |
| url | http://dx.doi.org/10.1016/s1359-6349(07)70929-1 |